IDEXX Laboratories, Inc.
IDXX
$528.68
-$5.24-0.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.45B | 4.30B | 4.17B | 4.04B | 3.93B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.45B | 4.30B | 4.17B | 4.04B | 3.93B |
| Cost of Revenue | 1.69B | 1.64B | 1.60B | 1.55B | 1.52B |
| Gross Profit | 2.76B | 2.66B | 2.57B | 2.48B | 2.41B |
| SG&A Expenses | 1.09B | 1.03B | 1.01B | 987.99M | 966.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.03B | 2.93B | 2.85B | 2.77B | 2.72B |
| Operating Income | 1.42B | 1.38B | 1.32B | 1.26B | 1.22B |
| Income Before Tax | 1.37B | 1.32B | 1.27B | 1.23B | 1.12B |
| Income Tax Expenses | 274.31M | 264.73M | 246.17M | 242.08M | 229.47M |
| Earnings from Continuing Operations | 1.10K | 1.06K | 1.03K | 985.66 | 894.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.10B | 1.06B | 1.03B | 985.66M | 894.97M |
| EBIT | 1.42B | 1.38B | 1.32B | 1.26B | 1.22B |
| EBITDA | 1.56B | 1.52B | 1.46B | 1.40B | 1.35B |
| EPS Basic | 13.69 | 13.18 | 12.71 | 12.11 | 10.91 |
| Normalized Basic EPS | 10.77 | 10.43 | 9.92 | 9.50 | 9.10 |
| EPS Diluted | 13.59 | 13.08 | 12.61 | 12.01 | 10.82 |
| Normalized Diluted EPS | 10.69 | 10.36 | 9.84 | 9.42 | 9.03 |
| Average Basic Shares Outstanding | 320.06M | 321.73M | 323.67M | 325.88M | 328.10M |
| Average Diluted Shares Outstanding | 322.31M | 324.07M | 326.13M | 328.51M | 330.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |